非オピオイド鎮痛パッチの世界市場レポート 2025年

非オピオイド鎮痛パッチ市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.3％で45億米ドルに成長します。予測期間における成長の背景には、研究開発投資の増加、ヘルスケア支出の増加、規制環境の整備、消費者の意識向上と教育、老人人口の拡大などがあります。予測期間における主な動向としては、ワイヤレスパッチやスマートパッチ技術、天然成分の統合、ウェアラブル技術との統合、生分解性で環境に優しいパッチ、長時間持続する効果への注目などが挙げられます。

慢性疼痛の有病率の増加は、今後数年間の非オピオイド鎮痛パッチ市場の成長を促進すると予想されます。慢性痛は、長期間続く激しい不快感や、別の病状と併発することが特徴です。非オピオイド系鎮痛パッチは、頭痛、筋肉痛、関節炎、腰痛、その他の様々な痛みを含む軽度から中等度の痛みを緩和するのに有効です。例えば、2023年11月、ルクセンブルクに本部を置く政府機関であるEurostatは、2022年にEUの個人の3分の1以上（36.1％）が長期的な（慢性的な）健康状態にあると回答したと報告しました。このように、慢性疼痛の有病率の上昇が非オピオイド鎮痛パッチ市場を押し上げています。

研究開発活動の活発化が非オピオイド鎮痛パッチ市場の成長をさらに促進すると予測されています。研究開発（R&D）には、既存の製品や手順を強化したり、新しいものを生み出したりすることを目的とした、企業や組織による調査努力が含まれます。特にパッチによる非オピオイド性疼痛管理ソリューションの進歩は、オピオイド依存や関連する副作用に関する懸念の高まりから、研究開発のダイナミックな分野として浮上しています。例えば、2024年1月、米国を拠点とする全米科学財団傘下の統計機関である全米科学技術統計センター（NCSES）は、米国における研究・実験開発（R&D）支出が2021年に7,891億米ドルに達し、2022年の推定総額は8,856億米ドルに達すると指摘しました。したがって、研究開発活動の増加が非オピオイド鎮痛パッチ市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界非オピオイド鎮痛パッチPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の非オピオイド鎮痛パッチ市場：成長率分析
• 世界の非オピオイド鎮痛パッチ市場の実績：規模と成長, 2019-2024
• 世界の非オピオイド鎮痛パッチ市場の予測：規模と成長, 2024-2029, 2034F
• 世界非オピオイド鎮痛パッチ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の非オピオイド鎮痛パッチ市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 完全に処理済み
• 半加工品
• 世界の非オピオイド鎮痛パッチ市場厚さ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 0.35 mm
• 0.5 mm
• 0.65 mm
• その他厚さ
• 世界の非オピオイド鎮痛パッチ市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• インダクタ
• トランスフォーマー
• モーター
• その他の用途
• 世界の非オピオイド鎮痛パッチ市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動車産業
• 航空
• 力
• 家庭用電化製品
• その他のエンドユーザー
• 世界の非オピオイド鎮痛パッチ市場、完全加工品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 冷間圧延電気鋼板
• 熱間圧延電気鋼板
• 世界の非オピオイド鎮痛パッチ市場、半加工品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 冷間圧延非方向性鋼
• 熱間圧延非方向性鋼

第7章 地域別・国別分析

• 世界の非オピオイド鎮痛パッチ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の非オピオイド鎮痛パッチ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 非オピオイド鎮痛パッチ市場：競合情勢
• 非オピオイド鎮痛パッチ市場：企業プロファイル
  • ThyssenKrupp AG Overview, Products and Services, Strategy and Financial Analysis
  • ArcelorMittal SA Overview, Products and Services, Strategy and Financial Analysis
  • Pohang Iron and Steel Company（POSCO）Overview, Products and Services, Strategy and Financial Analysis
  • Nippon Steel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Ansteel Group Corporation Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Shagang Group Co. Ltd.
• Shougang Group Co. Ltd.
• Baosteel Group Corporation
• JFE Holdings Inc.
• Tata Steel Limited
• United States Steel Corporation
• Voestalpine AG
• NoVo Lipetsk Steel
• Benxi Steel Group Co. Ltd
• Aperam S.A.
• China BaoWu Steel Group Corporation Limited
• Taiyuan Iron and Steel Co. Ltd.
• Malaysia Steel Works（KL）Bhd.
• CSC Steel Sdn. Bhd.
• Arnold Magnetic Technologies Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 非オピオイド鎮痛パッチ市場2029：新たな機会を提供する国
• 非オピオイド鎮痛パッチ市場2029：新たな機会を提供するセグメント
• 非オピオイド鎮痛パッチ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A non-opioid pain patch is a topical treatment designed to manage pain without the use of opioids. This non-systemic option is unique in providing prescription-strength relief. The patch delivers non-addictive medication directly to the affected area through the skin, allowing for effective pain management while reducing the risk of addiction and side effects associated with opioids. It is typically used to alleviate mild to moderate pain.

The primary types of non-opioid pain patches include lidocaine patches, diclofenac patches, capsaicin patches, ketoprofen patches, and others. Lidocaine patches, for instance, are transdermal patches with analgesic properties. These patches are composed of a synthetic amide-type anesthetic, lidocaine, formulated in a 5 percent aqueous base solution. They serve the purpose of aiding in the treatment of itching and pain associated with certain skin disorders. Lidocaine patches are distributed through various channels, including hospital pharmacies, retail pharmacies, and other outlets. These patches find applications in treating various conditions, including musculoskeletal pain and neuropathic pain.

The non-opioid pain patch research report is one of a series of new reports from The Business Research Company that provides non-opioid pain patch market statistics, including the non-opioid pain patch industry's global market size, regional shares, competitors with non-opioid pain patch market share, detailed non-opioid pain patch market segments, market trends and opportunities, and any further data you may need to thrive in the non-opioid pain patch industry. This non-opioid pain patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The non-opioid pain patch market size has grown strongly in recent years. It will grow from $3.48 billion in 2024 to $3.66 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increased chronic pain cases, patient preference for non-invasive treatment, improved formulations and ingredients, rise in sports injuries, and concerns over opioid addiction

The non-opioid pain patch market size is expected to see strong growth in the next few years. It will grow to $4.5 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing R&D investment, rising healthcare expenditure, a supportive regulatory environment, consumer awareness and education, and an expanding geriatric population. Major trends in the forecast period include wireless and smart patch technologies, integration of natural ingredients, integration with wearable technology, biodegradable and eco-friendly patches, and focus on long-lasting effects.

The increasing prevalence of chronic pain is anticipated to drive the growth of the non-opioid pain patch market in the coming years. Chronic pain is characterized by severe discomfort that persists for an extended period or occurs alongside another medical condition. Non-opioid pain patches are effective for alleviating mild to moderate pain, including headaches, muscle aches, arthritis, backaches, and various other pain types. For example, in November 2023, Eurostat, a government agency based in Luxembourg, reported that in 2022, over one-third (36.1%) of individuals in the EU indicated they had a long-term (chronic) health condition. Thus, the rising prevalence of chronic pain is boosting the non-opioid pain patch market.

Increasing research and development activities are projected to further propel the growth of the non-opioid pain patch market. Research and development (R&D) encompass the investigative efforts by a company or organization aimed at enhancing existing products and procedures or creating new ones. The advancement of non-opioid pain management solutions, particularly through patches, has emerged as a dynamic field for R&D, largely due to heightened concerns regarding opioid dependence and associated side effects. For instance, in January 2024, the National Center for Science and Engineering Statistics (NCSES), a US-based statistical agency under the National Science Foundation, noted that research and experimental development (R&D) expenditures in the United States reached $789.1 billion in 2021, with an estimated total of $885.6 billion for 2022. Therefore, the increase in research and development activities is driving the growth of the non-opioid pain patch market.

Product innovation is emerging as a prominent trend gaining traction in the non-opioid pain patch market, with major companies actively developing innovative solutions to enhance their market positions. An illustrative example is The Mentholatum Company Inc., a UK-based healthcare products manufacturer, which introduced the Deep Relief Actiflex Patch in June 2022. This drug-free pain patch features a cooling hydrogel containing water, offering fast cooling and soothing relief as the water evaporates on the skin. Specifically designed to treat aches and pains in muscles or joints, this innovative patch adds diversity to the non-opioid pain patch market.

Key players in the non-opioid pain patch market are focusing on the development of innovative products, including genetically validated target medicines. This approach involves creating drugs that specifically target biological pathways associated with diseases, guided by robust genetic evidence. Such a strategy enhances the effectiveness of treatments while minimizing the risk of side effects. For instance, in February 2024, Latigo Biotherapeutics Inc., a US-based biotechnology firm, introduced LTG-001, a selective inhibitor of the Nav1.8 sodium channel predominantly found in peripheral nerve cells. By targeting this specific channel, LTG-001 aims to interrupt pain signals at their origin, potentially offering effective pain relief without impacting the central nervous system. The results from Phase 1 clinical trials indicated that LTG-001 has a Tmax (time to maximum concentration) of approximately 1.5 hours, which implies a rapid onset of pain relief. This characteristic is particularly significant for managing both acute and chronic pain. Furthermore, LTG-001 is formulated for oral administration, providing a more convenient option for patients compared to injectable or topical treatments, thus enhancing compliance and ease of use.

In January 2024, Heron Therapeutics, a US-based biotechnology company specializing in non-opioid pain medications, formed a partnership with CrossLink Life Sciences. The goal of this collaboration is to broaden the sales network for ZYNRELEF, a pain-relief solution designed for orthopedic surgeries, throughout the United States. This partnership aims to increase product adoption, streamline access, and enhance post-operative pain management for a greater number of patients. CrossLink Life Sciences is a US-based private distributor specializing in orthopedic, spine, and sports medicine devices.

Major companies operating in the non-opioid pain patch market include Hisamitsu Pharmaceutical Co., Inc., Teikoku Pharma USA, Inc., Purdue Pharma L.P., Noven Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Grunenthal GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Medtronic plc, Abbott Laboratories, Bayer AG, Iroko Pharmaceuticals, LLC, Scilex Pharmaceuticals Inc., Zosano Pharma Corporation, Adynxx Inc., BioElectronics Corporation, NeuroMetrix Inc., Virpax Pharmaceuticals Inc., Eli Lilly and Company, Novartis AG, Amgen Inc., DURECT Corporation

North America was the largest region in the non-opioid pain patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-opioid pain patch market report during the forecast period. The regions covered in the non-opioid pain patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-opioid pain patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-opioid pain patch market consists of sales of aspirin, ibuprofen, and acetaminophen patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Opioid Pain Patch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-opioid pain patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-opioid pain patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-opioid pain patch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Patch: Lidocaine Patches; Diclofenac Patches; Capsaicin Patches; Ketoprofen Patches; Other Patches
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
• 3) By Indication: Musculoskeletal Pain; Neuropathic Pain
• Subsegments:
• 1) By Lidocaine Patches: 5% Lidocaine Patch; Other Concentrations
• 2) By Diclofenac Patches: 1.3% Diclofenac Patch; Other Concentrations
• 3) By Capsaicin Patches: 8% Capsaicin Patch; Other Concentrations
• 4) By Ketoprofen Patches: 5% Ketoprofen Patch; Other Concentrations
• 5) By Other Patches: Combination Patches; Herbal Extract Patches; Other Non-Opioid Patches
• Companies Mentioned: Hisamitsu Pharmaceutical Co., Inc.; Teikoku Pharma USA, Inc.; Purdue Pharma L.P.; Noven Pharmaceuticals, Inc.; Johnson & Johnson Services, Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Non-Opioid Pain Patch Market Characteristics

3. Non-Opioid Pain Patch Market Trends And Strategies

4. Non-Opioid Pain Patch Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Non-Opioid Pain Patch Growth Analysis And Strategic Analysis Framework

• 5.1. Global Non-Opioid Pain Patch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Non-Opioid Pain Patch Market Growth Rate Analysis
• 5.4. Global Non-Opioid Pain Patch Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Non-Opioid Pain Patch Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Non-Opioid Pain Patch Total Addressable Market (TAM)

6. Non-Opioid Pain Patch Market Segmentation

• 6.1. Global Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fully Processed
• Semi-processed
• 6.2. Global Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 0.35 mm
• 0.5 mm
• 0.65 mm
• Other Thickness
• 6.3. Global Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inductors
• Transformers
• Motors
• Other Applications
• 6.4. Global Non-Opioid Pain Patch Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automotive Industry
• Aviation
• Power
• Domestic Appliances
• Other End Users
• 6.5. Global Non-Opioid Pain Patch Market, Sub-Segmentation Of Fully Processed, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cold Rolled Electrical Steel
• Hot Rolled Electrical Steel
• 6.6. Global Non-Opioid Pain Patch Market, Sub-Segmentation Of Semi-Processed, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cold Rolled Non-Grain Oriented Steel
• Hot Rolled Non-Grain Oriented Steel

7. Non-Opioid Pain Patch Market Regional And Country Analysis

• 7.1. Global Non-Opioid Pain Patch Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Non-Opioid Pain Patch Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Non-Opioid Pain Patch Market

• 8.1. Asia-Pacific Non-Opioid Pain Patch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Non-Opioid Pain Patch Market

• 9.1. China Non-Opioid Pain Patch Market Overview
• 9.2. China Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Non-Opioid Pain Patch Market

• 10.1. India Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Non-Opioid Pain Patch Market

• 11.1. Japan Non-Opioid Pain Patch Market Overview
• 11.2. Japan Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Non-Opioid Pain Patch Market

• 12.1. Australia Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Non-Opioid Pain Patch Market

• 13.1. Indonesia Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Non-Opioid Pain Patch Market

• 14.1. South Korea Non-Opioid Pain Patch Market Overview
• 14.2. South Korea Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Non-Opioid Pain Patch Market

• 15.1. Western Europe Non-Opioid Pain Patch Market Overview
• 15.2. Western Europe Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Non-Opioid Pain Patch Market

• 16.1. UK Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Non-Opioid Pain Patch Market

• 17.1. Germany Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Non-Opioid Pain Patch Market

• 18.1. France Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Non-Opioid Pain Patch Market

• 19.1. Italy Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Non-Opioid Pain Patch Market

• 20.1. Spain Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Non-Opioid Pain Patch Market

• 21.1. Eastern Europe Non-Opioid Pain Patch Market Overview
• 21.2. Eastern Europe Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Non-Opioid Pain Patch Market

• 22.1. Russia Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Non-Opioid Pain Patch Market

• 23.1. North America Non-Opioid Pain Patch Market Overview
• 23.2. North America Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Non-Opioid Pain Patch Market

• 24.1. USA Non-Opioid Pain Patch Market Overview
• 24.2. USA Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Non-Opioid Pain Patch Market

• 25.1. Canada Non-Opioid Pain Patch Market Overview
• 25.2. Canada Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Non-Opioid Pain Patch Market

• 26.1. South America Non-Opioid Pain Patch Market Overview
• 26.2. South America Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Non-Opioid Pain Patch Market

• 27.1. Brazil Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Non-Opioid Pain Patch Market

• 28.1. Middle East Non-Opioid Pain Patch Market Overview
• 28.2. Middle East Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Non-Opioid Pain Patch Market

• 29.1. Africa Non-Opioid Pain Patch Market Overview
• 29.2. Africa Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Non-Opioid Pain Patch Market Competitive Landscape And Company Profiles

• 30.1. Non-Opioid Pain Patch Market Competitive Landscape
• 30.2. Non-Opioid Pain Patch Market Company Profiles
  • 30.2.1. ThyssenKrupp AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. ArcelorMittal SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pohang Iron and Steel Company (POSCO) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Nippon Steel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ansteel Group Corporation Limited Overview, Products and Services, Strategy and Financial Analysis

31. Non-Opioid Pain Patch Market Other Major And Innovative Companies

• 31.1. Shagang Group Co. Ltd.
• 31.2. Shougang Group Co. Ltd.
• 31.3. Baosteel Group Corporation
• 31.4. JFE Holdings Inc.
• 31.5. Tata Steel Limited
• 31.6. United States Steel Corporation
• 31.7. Voestalpine AG
• 31.8. NoVo Lipetsk Steel
• 31.9. Benxi Steel Group Co. Ltd
• 31.10. Aperam S.A.
• 31.11. China BaoWu Steel Group Corporation Limited
• 31.12. Taiyuan Iron and Steel Co. Ltd.
• 31.13. Malaysia Steel Works (KL) Bhd.
• 31.14. CSC Steel Sdn. Bhd.
• 31.15. Arnold Magnetic Technologies Corporation

32. Global Non-Opioid Pain Patch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non-Opioid Pain Patch Market

34. Recent Developments In The Non-Opioid Pain Patch Market

35. Non-Opioid Pain Patch Market High Potential Countries, Segments and Strategies

• 35.1 Non-Opioid Pain Patch Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Non-Opioid Pain Patch Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Non-Opioid Pain Patch Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer